Response to “Comment on ‘Medical use of all high activity sources should be eliminated for security concerns’ ” [Med. Phys. 42, 6773–6775 (2015)]

Por Capala, Jacek
Publicado no Med Phys (2016)

“Image and Treat” – An Individualized Approach to Urological Tumors

Por Bouchelouche, Kirsten, Capala, Jacek
Publicado em 2010

Molecular imaging of HER2-positive breast cancer - a step toward an individualized “Image and Treat” strategy

Por Capala, Jacek, Bouchelouche, Kirsten
Publicado em 2010

PET/CT AND RADIOIMMUNOTHERAPY OF PROSTATE CANCER

Por Bouchelouche, Kirsten, Capala, Jacek, Oehr, Peter
Publicado em 2009

Prostate Specific Membrane Antigen—A Target for Imaging and Therapy with Radionuclides

Por Bouchelouche, Kirsten, Choyke, Peter L, Capala, Jacek
Publicado em 2010

HER2 Expression Changes in Breast Cancer Xenografts Following Therapeutic Intervention Can Be Quantified Using PET Imaging and (18)F-Labelled Affibody Molecules.

Por Kramer-Marek, Gabriela, Kiesewetter, Dale O., Capala, Jacek
Publicado em 2009

Imaging Prostate Cancer: An Update on Positron Emission Tomography and Magnetic Resonance Imaging

Por Bouchelouche, Kirsten, Turkbey, Baris, Choyke, Peter, Capala, Jacek
Publicado em 2010

Targeted Radionuclide Therapy: Practical Applications and Future Prospects

Por Zukotynski, Katherine, Jadvar, Hossein, Capala, Jacek, Fahey, Frederic
Publicado no Biomark Cancer (2016)

Medical use of all high activity sources should be eliminated for security concerns

Por Capala, Jacek, Goetsch, Steven J., Orton, Colin G.
Publicado no Med Phys (2015)

Radiolabeling of HER2 specific Affibody® molecule with F-18

Por Kiesewetter, Dale O, Krämer-Marek, Gabriela, Ma, Ying, Capala, Jacek
Publicado em 2008

DESIGN OF LIPOSOMES CONTAINING PHOTOPOLYMERIZABLE PHOSPHOLIPIDS FOR TRIGGERED RELEASE OF CONTENTS

Por Yavlovich, Amichai, Singh, Alok, Tarasov, Sergey, Capala, Jacek, Blumenthal, Robert, Puri, Anu
Publicado em 2009

In Vivo Method to Monitor Changes in HER2 Expression Using Near-Infrared Fluorescence Imaging

Por Hassan, Moinuddin, Chernomordik, Victor, Zielinski, Rafal, Ardeshirpour, Yasaman, Capala, Jacek, Gandjbakhche, Amir
Publicado em 2012

In-vivo fluorescence lifetime imaging for monitoring the efficacy of the cancer treatment

Por Ardeshirpour, Yasaman, Chernomordik, Victor, Hassan, Moinuddin, Zielinski, Rafal, Capala, Jacek, Gandjbakhche, Amir
Publicado no Clin Cancer Res (2014)

Nanoscintillator Conjugates as Photodynamic Therapy-Based Radiosensitizers: Calculation of Required Physical Parameters

Por Morgan, Nicole Y., Kramer-Marek, Gabriela, Smith, Paul D., Camphausen, Kevin, Capala, Jacek
Publicado em 2009

PET/CT imaging and radioimmunotherapy of prostate cancer

Por Bouchelouche, Kirsten, Tagawa, Scott T., Goldsmith, Stanley J., Turkbey, Baris, Capala, Jacek, Choyke, Peter
Publicado em 2011

Sarcosine induces increase in HER2/neu expression in androgen-dependent prostate cancer cells

Por Dahl, Malin, Bouchelouche, Pierre, Kramer-Marek, Gabriela, Capala, Jacek, Nordling, Jörgen, Bouchelouche, Kirsten
Publicado em 2011

Quantitative analysis of HER2 receptors expression in vivo by NIR optical imaging

Por Chernomordik, Victor, Hassan, Moinuddin, Lee, Sang Bong, Zielinski, Rafal, Gandjbakhche, Amir, Capala, Jacek
Publicado em 2010

Polylactide-based Paclitaxel-loaded Nanoparticles Fabricated by Dispersion Polymerization: Characterization, Evaluation in Cancer Cell Lines, and Preliminary Biodistribution Studie...

Por Adesina, Simeon K., Holly, Alesia, Kramer-Marek, Gabriela, Capala, Jacek, Akala, Emmanuel O.
Publicado no J Pharm Sci (2014)

The crosstalk between EGF, IGF, and Insulin cell signaling pathways - computational and experimental analysis

Por Zielinski, Rafal, Przytycki, Pawel F, Zheng, Jie, Zhang, David, Przytycka, Teresa M, Capala, Jacek
Publicado em 2009

SimBoolNet—a Cytoscape plugin for dynamic simulation of signaling networks

Por Zheng, Jie, Zhang, David, Przytycki, Pawel F., Zielinski, Rafal, Capala, Jacek, Przytycka, Teresa M.
Publicado em 2010